Signaling Mechanisms Underlying A&bgr; Toxicity: Potential Therapeutic Targets for Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 355-361

Bentham Science Publishers

Access to resources Recommend Favorite

Reduction of A&bgr; Levels in the Sprague Dawley Rat After Oral Administration of the Functional g-Secretase Inhibitor, DAPT: A Novel Non- Transgenic Model for A&bgr; Production Inhibitors

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 671-676

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Modulation of A&bgr;42 Production in Alzheimer's Disease: Non-Steroidal Anti-Inflammatory Drugs and Beyond

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4337-4355

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors and Modulators of &bgr;- and &ggr;-Secretase

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-02 ,pp. : 377-392

Bentham Science Publishers

Access to resources Recommend Favorite

&bgr;-Lactams as Neuroprotective Agents

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 8, Iss. 1, 2009-01 ,pp. : 28-35

Bentham Science Publishers

Access to resources Recommend Favorite